Sonoma Pharmaceuticals (SNOA) Asset Utilization Ratio (2011 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Asset Utilization Ratio of 1.42 for Q1 2026, up 35.58% year-over-year from 1.04 in Q1 2025, and up 9.78% quarter-over-quarter from 1.29 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 1.42 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 35.58% year-over-year to 1.42; the TTM figure through Mar 2026 stood at 1.42 (up 35.58% YoY), while the FY2026 annual figure was 1.41, up 40.54% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 1.42, up from 1.29 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 1.42 in Q1 2026, with the low at 0.66 in Q1 2022.
- The 5-year median for Asset Utilization Ratio is 0.88 (2023), against an average of 0.95.
- Peak annual rise in Asset Utilization Ratio reached 36.35% in 2022, while the deepest fall reached 41.04% in 2022.
- Sonoma Pharmaceuticals' Asset Utilization Ratio stood at 0.87 in 2022, then gained by 0.25% to 0.87 in 2023, then grew by 17.24% to 1.02 in 2024, then climbed by 26.25% to 1.29 in 2025, then grew by 9.78% to 1.42 in 2026.
- Business Quant data shows SNOA's Asset Utilization Ratio at 1.42 in Q1 2026, 1.29 in Q4 2025, and 1.19 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | 1.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.37 |
| Mar 31, 2026 | 1.42 |
| Dec 31, 2025 | 1.29 |
| Sep 30, 2025 | 1.19 |
| Jun 30, 2025 | 1.05 |
| Mar 31, 2025 | 1.04 |
| Dec 31, 2024 | 1.02 |
| Sep 30, 2024 | 0.99 |
| Jun 30, 2024 | 0.89 |
| Mar 31, 2024 | 0.87 |
| Dec 31, 2023 | 0.87 |
| Sep 30, 2023 | 0.82 |
| Jun 30, 2023 | 0.79 |
| Mar 31, 2023 | 0.88 |
| Dec 31, 2022 | 0.87 |
| Sep 30, 2022 | 0.78 |
| Jun 30, 2022 | 0.72 |
| Mar 31, 2022 | 0.66 |
| Dec 31, 2021 | 0.64 |
| Sep 30, 2021 | 0.86 |